Gilead to present new data from their HIV and COVID-19 treatments

The FINANCIAL — Gilead Sciences, Inc. announced the presentation of 18 abstracts spanning the company’s HIV treatment and prevention and COVID-19 clinical development programs during the virtual IDWeek 2020 conference from October 21-25. The breadth of data reflects Gilead’s commitment to advancing…

7 mins read